For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Speaker Details

Beth Roxland JD, MBioethics Senior Advisor on Law, Policy and Bioethics Roxland Consultants Ltd New York, NY USA


Beth E. Roxland, J.D., M.Bioethics, is a leading Attorney & Health Policy expert with multifaceted experience across Industry, Law, Government & Academia. She founded Roxland Consultants Ltd. to leverage her unique expertise to provide comprehensive yet practical advice to life-science & biotech entities, law firms, hospitals & healthcare practitioners,clinical research sponsors and funders, and professional & patient associations, as they confront complex regulatory, ethical, operational & communications challenges. She frequently lectures and publishes on a variety of regenerative medicine, regulatory, public health, and bioethical topics, and has been cited in The Wall Street Journal, the New York Times, The Hill, and STAT. Beth previously served as Johnson & Johnson’s Bioethics and Strategy Leader, in the Office of the Chief Medical Officer, supporting all therapeutic areas, communications, regulatory and policy teams across all three divisions – pharmaceuticals, medical devices, and consumer products - providing ethical guidance for time-sensitive, real-world challenges encountered in global R&D, from the Ebola outbreak to Compassionate Use requests to conducting research in War-Torn regions. Prior to joining J&J, Ms. Roxland was the Executive Director of the New York State Task Force on Life and the Law, where she led the Task Force’s seminal work on the Allocation of Ventilators in a Pandemic, Determination of Brain Death, and Conducting Research with Adults Who Lack Full Consent Capacity. She was concurrently appointed to serve as the Special Advisor to the Commissioner of Health on Stem Cell Research Ethics, where she successfully formulated and ensured implementation of novel policies governing sensitive contentious ethical issues by leading transparent, consensus-building meetings of diverse stakeholders. Many of these policies – from compensation for oocyte donation to chimeric research to usage of embryos in government-funded stem cell research - still remain effective today. Prior to joining the government, Beth was a Senior Litigation Associate at Simpson Thacher & Bartlett LLP, and a federal judicial law clerk in the Southern District of New York (S.D.N.Y.). Beth graduated from Columbia University with a Bachelor’s degree in Biology and received her joint J.D. - Master’s in Bioethics magna cum laude from the University of Pennsylvania.